
First International Consensus on the diagnosis and management …
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD), which was commissioned by the working group 'Hypertension and the Kidney' of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM).
Recent Developments in the Understanding and Management …
2014年12月19日 · Fibromuscular dysplasia (FMD) is a nonatherosclerotic disease of medium‐sized vessels that can present with arterial stenosis, beading, dissection, and aneurysm. While the most common sites of FMD are the renal and extracranial carotid and vertebral arteries, FMD has been reported in most arterial segments. 1 FMD does not affect the venous ...
The United States Registry for Fibromuscular Dysplasia:
2012年5月21日 · Clinical features, presenting symptoms, and vascular events are reviewed for the first 447 patients enrolled in a national FMD registry from 9 US sites. Vascular beds were imaged selectively based on clinical presentation and local practice.
Expert consensus and evidence-based recommendations for the
2019年8月7日 · Endothelial function can be assessed non-invasively using the flow-mediated dilation (FMD) technique. Flow-mediated dilation represents an endothelium-dependent, largely nitric oxide (NO)-mediated dilatation of conduit arteries in response to an imposed increase in blood flow and shear stress.
肾动脉纤维肌性发育不良的治疗 - UpToDate
纤维肌性发育不良 (fibromuscular dysplasia, FMD)是一种非炎症性非动脉粥样硬化性疾病,可导致动脉狭窄、动脉瘤、动脉夹层和动脉扭曲 [1]。 目前几乎在所有动脉床中均已观察到FMD,最常受累的动脉为肾动脉和颈内动脉,其次是椎动脉、髂动脉及内脏动脉。 如果FMD发生在冠状动脉,患者通常会出现自发性冠状动脉夹层 (spontaneous coronary artery dissection, SCAD)引起的急性冠脉综合征 [2-7]。 根据受累动脉段和病情严重程度的不同,该病的表现可能有很大差异,最常 …
Fibromuscular Dysplasia: A Focused Review for the Cardiologist
Fibromuscular dysplasia (FMD) is an idiopathic, nonatherosclerotic, and noninflammatory arterial disease that affects small- to medium-sized arteries that can result in multifocal aneurysms, stenosis, tortuosity, and dissections.
Medscape专家访谈:肌纤维发育不良疾病的诊疗要点 - 丁香园
2014年8月28日 · 肌纤维发育不良(FMD)是一类较为罕见的血管内科疾病,而近几年的统计结果显示人群中罹患FMD的有所升高。 近日medscape网站邀请了4位FMD领域专家进行了访谈,从多方面介绍了FMD的研究及防治进展。
这种疾病,中国和西方表现不同!中国肾动脉纤维肌性发育不良共识
2023年2月27日 · 纤维肌性发育不良(FMD)是一种特发性、节段性、非炎症性、非动脉粥样硬化性的中小动脉疾病,最常累及肾动脉。 近日由中国医学科学院阜外医院蒋雄京、上海交通大学医学院附属瑞金医院许建忠等制定的《肾动脉纤维肌性发育不良诊断及处理中国专家共识》,总结国际已有研究结果并结合中国病例实际,制定了一系列诊疗规范。 5 种人群建议筛查肾动脉FMD. 据介绍,目前中国人群肾动脉FMD 患病率尚未见报道,如按肾动脉狭窄占成人高血压人群 …
Fibromuscular Dysplasia: State of the Science and Critical Unanswered ...
2014年2月18日 · Fibromuscular dysplasia (FMD) is nonatherosclerotic, noninflammatory vascular disease that may result in arterial stenosis, occlusion, aneurysm, or dissection. 1 – 3 The cause of FMD and its prevalence in the general population are not known. 4 FMD has been reported in virtually every arterial bed but most commonly affects the renal and ...
肾动脉纤维肌性发育不良致肾血管性高血压的诊断与治疗
分析肾动脉纤维肌性发育不良(fibromuscular dysplasia,FMD)致肾血管性高血压(renovascular hypertension,RVH)的临床特点及治疗效果。 回顾性分析2014年1月至2020年12月收治的38例肾动脉FMD并RVH患者的临床资料。 38例患者肾动脉CTA示40支肾动脉受累,其中多灶型狭窄6支,局灶型狭窄34支。 33例患者接受手术治疗,其中32例患者接受经皮肾动脉球囊扩张成形术,1例患者合并肾动脉瘤行肾动脉支架置入辅以动脉瘤弹簧圈栓塞治疗。 患者术后平均收缩压较术 …